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consequently reduce chances of survival. Models to predict 
acute dysphagia are available. However, these models were 
based on limited amounts of data and the performance of 
these models needs improvements before implementation 
into routine practice. Furthermore, Bayesian network models 
are shown to perform better than conventional modeling 
techniques on datasets with missing values, which is a 
common problem in routine clinical care. In this work, we 
train a Bayesian network model on a large clinical datasets, 
originating predominantly from routine clinical care, to 
accurately predict acute dysphagia in NSCLC patients during 
and shortly after (C)RT. 
 
Material and Methods: Clinical data from 1250 inoperable 
NSCLC patients, treated with radical CRT, sequential chemo-
radiation or RT alone were collected. The esophagus was 
delineated using the external esophageal contour from the 
cricoid cartilage to the GE junction. A Bayesian network 
model was developed to predict severe acute dysphagia (≥
Grade 3 according to the CTCAEv3.0 or v4.0). The model 
utilized age, mean esophageal dose, timing of chemotherapy 
and N-stage to make predictions. Variable selection and 
structure learning was done using the PC-algorithm. The 
model was trained on data from 1250 patients. The model’s 
performance was assessed internally and on an external 
validation set (N=218) from the United Kingdom. Model 
discriminative performance was expressed as the Area Under 
the Curve (AUC) of the Receiver Operating Characteristic 
(ROC). ROCs were compared using the method proposed by 
DeLong and colleagues. Model performance was also assessed 
in terms of calibration. Calibration refers to the agreement 
between the observed frequencies and the predicted 
probabilities and is expressed as the coefficient of 
determination (r2). 
 
Results: One-hundred forty patients (11,2%) developed acute 
dysphagia (≥ Grade 3 according to the CTCAEv3.0 or v4.0). 
The model was first validated internally, by validating on the 
training cohort (N=1250, AUC = 0.77, 95% CI: 0.7325-0.8086, 
r2 = 0.99). Subsequently, the model was externally validated 
on a UK dataset (N = 218, AUC = 0.81, 95% CI: 0.74-0.88, r2 = 
0.64). The ROC curves were not significantly different (p = 
0.28). 
 
Conclusion: The Bayesian network model can make accurate 
predictions of acute dysphagia (AUC = 0.77, 0.81 in the 
internal and external validation respectively), making it a 
powerful tool for clinical decision support. 
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Purpose or Objective: In the Dutch prostate hypo-
fractionation trial (19x3.4Gy versus 39x2Gy) a higher 
incidence of acute gastro-intestinal toxicity was observed in 
the experimental arm. We performed model estimations 
using various alpha/beta ratios to determine whether this 
difference can be explained according to the linear-quadratic 
model. 
 
Material and Methods: Patients with localized prostate 
cancer were randomized between standard fractionation 
(SF=5x2Gy per week, N=293) and hypo-fractionation 
(HF=3x3.4Gy per week, N=285). Proctitis (grade ≥2) was 
defined as moderate to severe mucous or blood loss, or mild 
mucous or blood loss combined with at least 2 other 
complaints: diarrhea, incontinence, tenesmus, cramps, pain. 
Peak incidences over treatment weeks 4 and 6 were available 
from prospectively collected patient reports. Normalized 
Total Dose (NTD, 2Gy equivalent) was accumulated per week 
for alpha/beta ratios of 3, 5, 10, and ∞ (=physical dose), and 
used to derive relative Dose-Surface Histograms (DSHs) of the 
delineated anorectum for each patient. Maximum likelihood 
logistic regressions were performed using a DSH point as 
variable. Univariate (UV) models and multivariate (MV) 
models with fractionation schedule as factor were 
constructed. 
 
Results: Acute proctitis incidences were highest for hypo-
fractionation (SF: n=67; 22.9%, HF: n=98; 34.3%, p<0.01). The 
7Gy/week DSH point correlated well with proctitis, and was 
used for subsequent modeling. Figure 1 illustrates the models 
for the various alpha/beta ratios, and incidences for five 
(roughly) equal size patient bins. Note that the NTD 
correction decreases the surface areas that receive <2Gy per 
day, and increases surfaces receiving >2Gy. The central NTD 
values of the patient bins therefore lie at higher values for 
HF than for SF. The MV models have higher likelihood than 
the UV models, but likelihood for different alpha/beta ratios 
is similar. All MV models have odds ratios >1.5 (p<0.05) for HF 
versus SF, i.e. fractionation remains a factor. 
 
Conclusion: Linear-quadratic dose correction cannot explain 
the observed acute rectum toxicity difference between hypo-
fractionated and standard treatment in patients with 
prostate cancer. Subsequent modeling will concentrate on 
alternative mechanisms. 
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Purpose or Objective: To explore whether spatial dose 
measures explain the occurrence of rectal leakage, 
obstruction, and urgency after radiotherapy (RT) for localized 
prostate cancer. 
 
Material and Methods: Spatial dose measures were extracted 
for 210 patients treated with RT in 2005-2007, and who all 
completed patient-reported outcomes (PROs) at a median of 
3.6 years post-RT. The rectum was digitally unfolded and 2D 
maps were created for each patient by interpolating across 
25 points for 45º-sectors of each contour. The areas and 
extents (lateral and longitudinal) were calculated for dose 
thresholds between 35 and 75 Gy in 5 Gy steps over 9 equally 
distributed segments over the 2D maps (Fig. 1A), and their 
lateral and longitudinal combinations, resulting in a total of 
216 spatial dose metrics. Univariate (UVA) followed by 
multivariate (MVA) analysis using logistic regression with 50 
times iterated 5-fold cross-validation was applied to 
investigate the relationship between the spatial measures 
and ‘at least a moderate severity’ of five symptoms related 
to defecation urgency, fecal leakage, or obstruction. The 
prevalence for all investigated symptoms was ³ 25%. The UVA 
and MVA were first conducted in 70% of the data, and the 
performance of the most frequent MVA model, judged by the 
area under the receiver-operating characteristics curve 
(AUC), was investigated in the complete cohort. 
 
Results: On UVA 3-11 metrics (mean±SD: AUC=0.58±0.11) 
were suggested as potential predictors for the investigated 
symptoms (Table 1). The AUC of the final MVA models was 
0.57-0.62 (Fig. 1B). Defecation urgency was explained by 
metrics related to high doses (>55 Gy), fecal leakage was 
governed by medium to high-dose extensions in the anterior 
part of the rectum, and obstruction by metrics related to the 
lower part of the rectum, as well as extents of the high dose 
(>75 Gy).  
 
 
 
 
Conclusion: Our analysis suggests that spatial dose metrics 
explain symptoms of the gastrointestinal tract such as 
defecation urgency, fecal leakage and obstruction, and that 
these symptoms present spatial-specific relationships. The 
robustness of these results will be explored in other available 
cohorts (N>500) to evaluate whether these findings, and 
spatial dose metrics in general should be taken into account 
in the RT planning and treatment for localized prostate 
cancer. 
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Purpose or Objective: To investigate the relationship 
between patient-reported acute urinary (GU) toxicity (tox) 
and bladder local dose distribution in patients (pts) treated 
with radical RT for prostate cancer (PCa) by a pixel-wise 
method for analysis of bladder surface dose maps (DSMs). 
 
Material and Methods: Analyses were performed on the final 
cohort of pts of a multi-centric study, consisting of 539 pts 
with PCa treated with conventionally (CONV: 1.8 – 2Gy/fr) or 
moderately hypo-fractionated RT (HYPO: 2.2-2.7 Gy/fr) in 5 
fx/week. GU tox was evaluated by the International Prostate 
Symptoms Score (IPSS) given to the pts at the beginning and 
at the end of RT, comprising 7 questions relating to different 
symp: feeling of incomplete emptying (EMP), frequency 
(FRE), intermittency (INT), urgency (URG), weak stream 
(WST), straining (STR) and nocturia (NOC). We here 
considered the seven symp separately and moderate/severe 
tox for each item was selected as endpoint (score ≥4 at RT 
end), including only pts who had no disturbs before RT (IPSS 
at basal < 4). As different fractionation schemes were 
allowed, DSMs of all pts were corrected into 2Gy-equivalent 
maps using the LQ model, converting the dose in each pixel 
with an α/β equal to 10 Gy and a repair factor =0.7 Gy/day. 
DSMs of all pts were generated by unfolding the bladder: its 
contour was cut anteriorly at the points intersecting the 
sagittal plane passing through its centre of mass, normalised 
in the axial direction and aligned at the bladder base, at the 
posterior central point, generating a common frame for all 
pts. For each endpoint average DSMs of pts with/without tox 
were compared pixel by-pixel by two-sided t-tests, 
separately analyzing HYPO and CONV pts: the resulting p-
value maps were used for identifying the regions better 
discriminating between pts with/without tox, considering a 
threshold of p<0.01. 
 
Results: DSMs of 437/539 pts (81%) were available (185 CONV 
and 252 HYPO). EMP was reported by 28/358 (8%) pts, FRE by 
60/361 (17%), INT by 35/366 (10%), URG by 50/357 (14%), 
WST by 66/341 (19%), STR by 29/377 (8%) and NOC by 63/348 
(18%) pts. For HYPO pts, areas significantly correlated with 
GU tox were found for all endpoints (excepting WST) in the 
posterior region at 5-17 mm from the base of bladder, 
consistently with the bladder trigone, with evidence of a 
threshold effect around 85 Gy (2Gy equivalent). For CONV 
pts, only 2 endpoints (FRE and URG) showed significantly 
predictive areas, robustly summarized in the % surface 
receiving >50-70Gy at 5mm from the base and the vertical 
extension of 50-70Gy isodoses along the bladder central axis. 
In the figure, the results concerning FRE and URG are shown. 
